ZS Pharma Announces Multiple ZS-9 Data Presentations at Upcoming Medical Meetings
May 12, 2015 08:00 ET
|
ZS Pharma
REDWOOD CITY, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed...
ZS Pharma Reports First Quarter 2015 Financial Results and Provides ZS-9 Program Update
May 11, 2015 16:01 ET
|
ZS Pharma
REDWOOD CITY, Calif., May 11, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed...
ZS Pharma to Present at Bank of America Merrill Lynch 2015 Health Care Conference
May 06, 2015 08:00 ET
|
ZS Pharma
REDWOOD CITY, Calif., May 6, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed...
ZS Pharma Appoints Kimberly Popovits to Board of Directors
May 05, 2015 16:00 ET
|
ZS Pharma
REDWOOD CITY, Calif., May 5, 2015 (GLOBE NEWSWIRE) -- ZS Pharma (Nasdaq:ZSPH), a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today...
ZS Pharma Announces Publications in Peer-Reviewed Medical Journals
April 15, 2015 17:02 ET
|
ZS Pharma
-- NEJM letter to the Editor highlights rapid efficacy in patients with severe hyperkalemia –
-- Phase 2 first-in-man study of ZS-9 published in Kidney International –
REDWOOD...
ZS Pharma Announces Upsizing and Pricing of $186 Million Public Offering of Common Stock
March 25, 2015 00:46 ET
|
ZS Pharma
REDWOOD CITY, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed...
ZS Pharma Announces Proposed Public Offering of Common Stock
March 23, 2015 16:13 ET
|
ZS Pharma
REDWOOD CITY, Calif., March 23, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed...
ZS Pharma to Present Data From Phase 3 Trials of ZS-9 in Presentations at the National Kidney Foundation 2015 Spring Clinical Meetings
March 19, 2015 08:00 ET
|
ZS Pharma
REDWOOD CITY, Calif., March 19, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed...
ZS Pharma Reports Fourth Quarter and Year-End 2014 Financial Results and Provides ZS-9 Program Update
March 13, 2015 07:00 ET
|
ZS Pharma
REDWOOD CITY, Calif., March 13, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed...
ZS Pharma Hires Key Medical Affairs and Commercial Executives
February 19, 2015 08:00 ET
|
ZS Pharma
– As ZS-9 Nears NDA and MAA Submissions, ZS Pharma Adds Key Members to Its Medical Affairs and Commercial Leadership Team –
REDWOOD CITY, Calif., Feb. 19, 2015 (GLOBE NEWSWIRE) -- ZS...